Teva Canada recalls some Pregabalin capsules over sertraline contamination concerns

Teva Canada is recalling some of its Teva-Pregabalin 150 mg capsules after it said routine testing identified possible contamination with the drug sertraline.

The items were first sold in Canada in September 2025 and have an expiration date of July 31, 2027.

"Patients with a hypersensitivity or allergy to sertraline could experience side effects or have a serious allergic reaction, including an anaphylactic reaction, even at a low exposure," according to a recall notice from Health Canada , noting anaphylactic reactions can be fatal.

The agency said anyone with products from the above-mentioned lots should return them to a pharmacy as soon as possible.

Pregabalin is a prescription drug used to treat pain caused by nerve damage. Sertraline is another prescription drug used to relieve symptoms of depression, obsessive-compulsive disorder and panic disorders.

Toronto-based Teva Canada said in its recall notice on Friday that the move is a "precautionary measure."